BAKER BROS. ADVISORS LP

Holdings History for Candel Therapeutics, Inc. - Common Stock (CADL)

Symbol: CADL on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 2,455,108 shares
Security Ownership %: 5%

Shares, Excluding Options vs Price

Value, Excluding Options

Baker Bros. Advisors LP ownership in Candel Therapeutics, Inc. Common Stock (CADL)

15 May 2025 - Baker Bros. Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,455,108 shares of Candel Therapeutics, Inc. Common Stock (CADL). This represents 5% ownership of the company. In their previous filing dated 14 Feb 2025, BAKER BROS. ADVISORS LP had reported owning 2,981,983 shares, indicating a decrease of +18%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Baker Bros. Advisors LP	5%	-26%	$11,882,723	2,455,108	-526,875	-18%	$4.84	13G/A	31 Mar 2025	15 May 2025, 16:33
Baker Bros. Advisors LP	6.8%		$14,432,798	2,981,983			$4.84	13G	31 Dec 2024	14 Feb 2025, 16:14

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2025		-0.02%	$0	0	-355,112	-100%	$5.60	Q3 2025
30 Jun 2025	0.02%	-0.1%	$1,796,867	355,112	-2,082,077	-85%	$5.06	Q2 2025
31 Mar 2025	0.15%	-0.03%	$13,770,118	2,437,189	-544,794		$5.65	Q1 2025
31 Dec 2024	0.28%	+0.28%	$25,883,612	2,981,983	+2,981,983	NEW	$8.68	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.